Glabretal-type triterpenoid from the root bark of Dictamnus dasycarpus ameliorates collagen-induced arthritis by inhibiting Erk-dependent lymphocyte proliferation

Sang Pil Choi, Chang Yong Choi, Kyungmin Park, Nahyun Kim, Hyun-Seuk Moon, Dongho Lee, Taehoon Chun

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Ethnopharmacological relevance The root bark of Dictamnus dasycarpus Turcz. (Rutaceae) has been used as a traditional herbal medicine to treat various inflammatory diseases in East Asia. We have showed previously that a glabretal type triterpenoid (dictabretol A) from D. dasycarpus root bark has immunosuppressive activity. Aim of the study This study was conducted to define the molecular mechanism of how dictabretol A inhibits lymphocyte proliferation and to evaluate the therapeutic efficacy of dictabretol A in an animal model of rheumatoid arthritis. Materials and methods Various murine immune cells (T cells, B cells, and macrophages) and splenocytes were used to study the anti-proliferative effect of dictabretol A in vitro. A collagen-induced arthritis model was also used to examine the therapeutic effect of dictabretol A in vivo. Results Dictabretol A specifically inhibited lymphocyte proliferation by blocking the cell cycle transition from the G1 to the S phase. This effect was achieved by blocking Erk1/2, nuclear factor kappa B, and the C-myc axis of cell cycle progression. Further dictabretol A treatment alleviated the severity of collagen-induced arthritis. Conclusion Our results reveal the molecular mechanism for the anti-lymphoproliferative effect of dictabretol A and show the therapeutic efficacy of dictabretol A for rheumatoid arthritis.

Original languageEnglish
Pages (from-to)13-16
Number of pages4
JournalJournal of Ethnopharmacology
Volume178
DOIs
Publication statusPublished - 2016 Feb 3

Fingerprint

Dictamnus
Experimental Arthritis
Lymphocytes
Rheumatoid Arthritis
Cell Cycle
Rutaceae
Far East
Herbal Medicine
NF-kappa B
Traditional Medicine
Therapeutic Uses
Immunosuppressive Agents
S Phase
B-Lymphocytes
Therapeutics
Animal Models
Macrophages
T-Lymphocytes

Keywords

  • Cell cycle
  • Collagen inducedarthritis
  • DictabretolA
  • Lymphocyte
  • Signal transductio

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this

@article{7e663ed608fa48adb0c6bd2514de4a2c,
title = "Glabretal-type triterpenoid from the root bark of Dictamnus dasycarpus ameliorates collagen-induced arthritis by inhibiting Erk-dependent lymphocyte proliferation",
abstract = "Ethnopharmacological relevance The root bark of Dictamnus dasycarpus Turcz. (Rutaceae) has been used as a traditional herbal medicine to treat various inflammatory diseases in East Asia. We have showed previously that a glabretal type triterpenoid (dictabretol A) from D. dasycarpus root bark has immunosuppressive activity. Aim of the study This study was conducted to define the molecular mechanism of how dictabretol A inhibits lymphocyte proliferation and to evaluate the therapeutic efficacy of dictabretol A in an animal model of rheumatoid arthritis. Materials and methods Various murine immune cells (T cells, B cells, and macrophages) and splenocytes were used to study the anti-proliferative effect of dictabretol A in vitro. A collagen-induced arthritis model was also used to examine the therapeutic effect of dictabretol A in vivo. Results Dictabretol A specifically inhibited lymphocyte proliferation by blocking the cell cycle transition from the G1 to the S phase. This effect was achieved by blocking Erk1/2, nuclear factor kappa B, and the C-myc axis of cell cycle progression. Further dictabretol A treatment alleviated the severity of collagen-induced arthritis. Conclusion Our results reveal the molecular mechanism for the anti-lymphoproliferative effect of dictabretol A and show the therapeutic efficacy of dictabretol A for rheumatoid arthritis.",
keywords = "Cell cycle, Collagen inducedarthritis, DictabretolA, Lymphocyte, Signal transductio",
author = "Choi, {Sang Pil} and Choi, {Chang Yong} and Kyungmin Park and Nahyun Kim and Hyun-Seuk Moon and Dongho Lee and Taehoon Chun",
year = "2016",
month = "2",
day = "3",
doi = "10.1016/j.jep.2015.10.043",
language = "English",
volume = "178",
pages = "13--16",
journal = "Journal of Ethnopharmacology",
issn = "0378-8741",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Glabretal-type triterpenoid from the root bark of Dictamnus dasycarpus ameliorates collagen-induced arthritis by inhibiting Erk-dependent lymphocyte proliferation

AU - Choi, Sang Pil

AU - Choi, Chang Yong

AU - Park, Kyungmin

AU - Kim, Nahyun

AU - Moon, Hyun-Seuk

AU - Lee, Dongho

AU - Chun, Taehoon

PY - 2016/2/3

Y1 - 2016/2/3

N2 - Ethnopharmacological relevance The root bark of Dictamnus dasycarpus Turcz. (Rutaceae) has been used as a traditional herbal medicine to treat various inflammatory diseases in East Asia. We have showed previously that a glabretal type triterpenoid (dictabretol A) from D. dasycarpus root bark has immunosuppressive activity. Aim of the study This study was conducted to define the molecular mechanism of how dictabretol A inhibits lymphocyte proliferation and to evaluate the therapeutic efficacy of dictabretol A in an animal model of rheumatoid arthritis. Materials and methods Various murine immune cells (T cells, B cells, and macrophages) and splenocytes were used to study the anti-proliferative effect of dictabretol A in vitro. A collagen-induced arthritis model was also used to examine the therapeutic effect of dictabretol A in vivo. Results Dictabretol A specifically inhibited lymphocyte proliferation by blocking the cell cycle transition from the G1 to the S phase. This effect was achieved by blocking Erk1/2, nuclear factor kappa B, and the C-myc axis of cell cycle progression. Further dictabretol A treatment alleviated the severity of collagen-induced arthritis. Conclusion Our results reveal the molecular mechanism for the anti-lymphoproliferative effect of dictabretol A and show the therapeutic efficacy of dictabretol A for rheumatoid arthritis.

AB - Ethnopharmacological relevance The root bark of Dictamnus dasycarpus Turcz. (Rutaceae) has been used as a traditional herbal medicine to treat various inflammatory diseases in East Asia. We have showed previously that a glabretal type triterpenoid (dictabretol A) from D. dasycarpus root bark has immunosuppressive activity. Aim of the study This study was conducted to define the molecular mechanism of how dictabretol A inhibits lymphocyte proliferation and to evaluate the therapeutic efficacy of dictabretol A in an animal model of rheumatoid arthritis. Materials and methods Various murine immune cells (T cells, B cells, and macrophages) and splenocytes were used to study the anti-proliferative effect of dictabretol A in vitro. A collagen-induced arthritis model was also used to examine the therapeutic effect of dictabretol A in vivo. Results Dictabretol A specifically inhibited lymphocyte proliferation by blocking the cell cycle transition from the G1 to the S phase. This effect was achieved by blocking Erk1/2, nuclear factor kappa B, and the C-myc axis of cell cycle progression. Further dictabretol A treatment alleviated the severity of collagen-induced arthritis. Conclusion Our results reveal the molecular mechanism for the anti-lymphoproliferative effect of dictabretol A and show the therapeutic efficacy of dictabretol A for rheumatoid arthritis.

KW - Cell cycle

KW - Collagen inducedarthritis

KW - DictabretolA

KW - Lymphocyte

KW - Signal transductio

UR - http://www.scopus.com/inward/record.url?scp=84954123492&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84954123492&partnerID=8YFLogxK

U2 - 10.1016/j.jep.2015.10.043

DO - 10.1016/j.jep.2015.10.043

M3 - Article

VL - 178

SP - 13

EP - 16

JO - Journal of Ethnopharmacology

JF - Journal of Ethnopharmacology

SN - 0378-8741

ER -